tumor peptide-loaded myeloid dendritic cells
Term · Oncology and biomedicine · MLC-T-ONC-017368
A cell-based cancer vaccine composed of myeloid dendritic cells (myDCs) pulsed with tumor peptides with potential immunostimulatory and antineoplastic activities. Upon administration, the tumor peptide-loaded myDCs stimulate a specific cytotoxic T-lymphocyte (CTL) response against the tumor cells, resulting in tumor cell lysis.
| Identifier | MLC-T-ONC-017368 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | tumor peptide-loaded myDC vaccine |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-017368",
"term": "tumor peptide-loaded myeloid dendritic cells",
"field": "Oncology and biomedicine",
"definition": "A cell-based cancer vaccine composed of myeloid dendritic cells (myDCs) pulsed with tumor peptides with potential immunostimulatory and antineoplastic activities. Upon administration, the tumor peptide-loaded myDCs stimulate a specific cytotoxic T-lymphocyte (CTL) response against the tumor cells, resulting in tumor cell lysis.",
"synonyms": [
"tumor peptide-loaded myDC vaccine"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/tumor-peptide-loaded-myeloid-dendritic-cells/"
}
Record 16,832 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.